These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 38275101)

  • 1. The phenotypic reversion of cancer: Experimental evidences on cancer reversibility through epigenetic mechanisms (Review).
    Pensotti A; Bizzarri M; Bertolaso M
    Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38275101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor reversion and embryo morphogenetic factors.
    Proietti S; Cucina A; Pensotti A; Fuso A; Marchese C; Nicolini A; Bizzarri M
    Semin Cancer Biol; 2022 Feb; 79():83-90. PubMed ID: 32920125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Cancer Reversible? Rethinking Carcinogenesis Models-A New Epistemological Tool.
    Pensotti A; Bertolaso M; Bizzarri M
    Biomolecules; 2023 Apr; 13(5):. PubMed ID: 37238604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the specific epigenetic alterations associated with chemo-resistance via reprogramming of cancer cells.
    Kim JJ; Rai R
    Med Hypotheses; 2015 Dec; 85(6):710-4. PubMed ID: 26527497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Reversion: Mesenchymal-Epithelial Transition as a Critical Step in Managing the Tumor-Microenvironment Cross-Talk.
    Bizzarri M; Cucina A; Proietti S
    Curr Pharm Des; 2017; 23(32):4705-4715. PubMed ID: 28629307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mathematical models of cell phenotype regulation and reprogramming: Make cancer cells sensitive again!
    Wooten DJ; Quaranta V
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):167-175. PubMed ID: 28396217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Differentiation Stage Factors and their Role in Triggering Symmetry Breaking Processes during Cancer Development: A Quantum Field Theory Model for Reprogramming Cancer Cells to Healthy Phenotypes.
    Biava PM; Burigana F; Germano R; Kurian P; Verzegnassi C; Vitiello G
    Curr Med Chem; 2019; 26(6):988-1001. PubMed ID: 28933288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenopatients 2.0: reprogramming the epigenetic landscapes of patient-derived cancer genomes.
    Menendez JA; Alarcón T; Corominas-Faja B; Cuyàs E; López-Bonet E; Martin AG; Vellon L
    Cell Cycle; 2014; 13(3):358-70. PubMed ID: 24406535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic morphogenetic field induces phenotypic reversion in cancer cells. Review article.
    Bizzarri M; Cucina A; Biava PM; Proietti S; D'Anselmi F; Dinicola S; Pasqualato A; Lisi E
    Curr Pharm Biotechnol; 2011 Feb; 12(2):243-53. PubMed ID: 21044001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The causal relationship between epigenetic abnormality and cancer development: in vivo reprogramming and its future application.
    Yamada Y; Yamada Y
    Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(6):235-247. PubMed ID: 29887568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy.
    Sell S; Nicolini A; Ferrari P; Biava PM
    Curr Drug Targets; 2016; 17(10):1103-10. PubMed ID: 26343109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1.
    Tuynder M; Susini L; Prieur S; Besse S; Fiucci G; Amson R; Telerman A
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14976-81. PubMed ID: 12399545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic modifications of c-MYC: Role in cancer cell reprogramming, progression and chemoresistance.
    Fatma H; Maurya SK; Siddique HR
    Semin Cancer Biol; 2022 Aug; 83():166-176. PubMed ID: 33220458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetics in cancer.
    Sharma S; Kelly TK; Jones PA
    Carcinogenesis; 2010 Jan; 31(1):27-36. PubMed ID: 19752007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular reprogramming and cancer development.
    Semi K; Matsuda Y; Ohnishi K; Yamada Y
    Int J Cancer; 2013 Mar; 132(6):1240-8. PubMed ID: 23180619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chick embryo extract demethylates tumor suppressor genes in osteosarcoma cells.
    Mu X; Sultankulov B; Agarwal R; Mahjoub A; Schott T; Greco N; Huard J; Weiss K
    Clin Orthop Relat Res; 2014 Mar; 472(3):865-73. PubMed ID: 23761177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concise review: dedifferentiation meets cancer development: proof of concept for epigenetic cancer.
    Yamada Y; Haga H; Yamada Y
    Stem Cells Transl Med; 2014 Oct; 3(10):1182-7. PubMed ID: 25122691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural products in the reprogramming of cancer epigenetics.
    Irshad R; Husain M
    Toxicol Appl Pharmacol; 2021 Apr; 417():115467. PubMed ID: 33631231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.